BioRestorative Therapies

About:

BioRestorative Therapies develop medical procedures using cell and tissue protocols for patients to undergo cellular based treatments.

Website: http://biorestorative.com

Twitter/X: biorestorative

Top Investors: NSF Small Business Innovation Research / Small Business Technology Transfer (SBIR/STTR), The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Description:

BioRestorative Therapies is a development stage company, develops medical procedures using cell and tissue protocols, primarily involving adult stem cells, designed for patients to undergo minimally invasive cellular-based treatments. The company focuses on the development of the ThermoStem Program that engages in the use of brown fat in connection with the cell-based treatment of Type 2 diabetes, obesity, hypertension, other metabolic disorders, and cardiac deficiencies, as well as is involved in the study of stem cells, several genes, proteins, and/or mechanisms, which are related to these diseases and disorders. It also focuses on the development of brtxDISC (Disc Implanted Stem Cells) Program for the adult stem cell treatment of disc and spine conditions, including bulging and herniated discs.